These tumors exhibit elevated c-MYC expression, and the authors used CDK1 siRNA delivered by cationic lipid assisted nanoparticles to induce decreased cell viability and apoptosis only in c-MYC overexpressed triple-negative breast cancers and not in normal mammary epithelial cells. The gene discussed is MYC; the disease is triple-negative breast carcinoma.